Genomic Cancer Panel And Profiling Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Projected Growth of the Genomic Cancer Panel And Profiling Market?
In recent times, the market for genomic cancer panel and profiling has seen considerable growth. It is forecasted to increase from $9.47 billion in 2024 to $10.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.9%. Several factors have facilitated this growth, including the escalating global cancer prevalence, the widespread use in clinical trials, the expansion of diagnostic facilities, heightened awareness about genetic testing, and a surge in government and research funding.

The market size for genomic cancer panel and profiling is predicted to experience significant expansion in the upcoming years. It is projected to reach $14.37 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. This growth during the projected period is due to factors such as the surge in liquid biopsy applications, its increasing utility for early detection, the rise in tailored therapies, and growing number of companion diagnostics approvals. Key trends for the anticipated period comprise the incorporation of AI and machine learning in genomic data analysis, advancement of multi-omics methods, cloud-storage and evaluation of genomic data, integration with electronic health records, and proliferation of next-generation sequencing (NGS) platforms.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24225&type=smp

What Are the Different Genomic Cancer Panel And Profiling Market Segments?
The genomic cancer panel and profiling market covered in this report is segmented -

1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users

Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp

What Are the Primary Drivers Shaping the Genomic Cancer Panel And Profiling Market?
The anticipated growth of the genomic cancer panel and profiling market is largely linked to the growing prevalence of cancer. Cancer is marked by unchecked cell growth and spread, resulting in abnormal cell replication within the body. The spike in cancer rates often correlates to factors including an aging population that faces a heightened cancer risk due to longer life spans. Genomic cancer panels and profiling techniques are frequently applied in cancer diagnosis for the identification of genetic mutations and biomarkers, which in turn facilitates personalized therapeutic interventions, boosts early detection, and aids in continuous disease monitoring. For instance, statistics from the American Cancer Society reported approximately 20 million fresh cancer diagnoses worldwide in 2022, leading to 9.7 million fatalities; a surge significantly driven by population increase. It is further predicted that the number of cancer cases will reach 35 million by 2050. Therefore, the escalating incidence of cancer will in all likelihood stimulate the growth of the genomic cancer panel and profiling market.

Which Companies Are Leading in the Genomic Cancer Panel And Profiling Market?
Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.

What Genomic Cancer Panel And Profiling Market Trends Are Gaining Traction Across Different Segments?
Leading firms active in the genomic cancer panel and profiling market are prioritizing technological innovation, such as next-generation sequencers, to enhance the precision, pace, and completeness of cancer diagnosis, thereby supporting more tailored treatment plans. Advanced DNA sequencing technologies known as next-generation sequencers facilitate swift, intensive genetic analysis to detect mutations, variations, and other genomic characteristics. For instance, in April 2025, Netherland's leading biotech company, QIAGEN N.V., introduced QIAseq panels compatible with next-generation sequencers, capable of undertaking a holistic genomic profiling by studying over 700 genes. These panels, developed for both research and clinical uses, are set with the goal of refining cancer diagnosis and treatment approaches.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/genomic-cancer-panel-and-profiling-global-market-report

What Are the Top Revenue-Generating Geographies in the Genomic Cancer Panel And Profiling Market?
North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Genomic Cancer Panel And Profiling Market?
2. What is the CAGR expected in the Genomic Cancer Panel And Profiling Market?
3. What Are the Key Innovations Transforming the Genomic Cancer Panel And Profiling Industry?
4. Which Region Is Leading the Genomic Cancer Panel And Profiling Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.